Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results.

Arthritis Care Res (Hoboken) · 2020 · PMC7589221 · PMID 31421019

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

New users in the ADA ± MTX arm showed a trend toward lower mean JADAS‐27 CRP compared with new users in the MTX arm in the first year of STRIVE.

also in 53,322 other papers

a numerical trendno p-value reported

There was a numerical trend toward earlier improvement in the ADA – MTX and ADA + MTX new users compared with the MTX new users, resulting in lower mean disease activity in the first 12 months of registry follow‐up in ADA – MTX and ADA + MTX new users.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.